image
Healthcare - Biotechnology - NASDAQ - CH
$ 2.08
0 %
$ 206 M
Market Cap
-3.14
P/E
Price Target Average
--100.00%
Revenue Forecast Estimate
80.31%
EBIT Estimate
--34.85%
Net Income Estimate
52.87%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets AC Immune S.A.
image
ACIU has no price targets from Wall Street.
REVENUE FORECAST

Revenue Forecast Chart ACIU

image
$300.0m$300.0m$250.0m$250.0m$200.0m$200.0m$150.0m$150.0m$100.0m$100.0m$50.0m$50.0m$0.0$0.02016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart ACIU

image
$50.0m$50.0m$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)2016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart ACIU

image
$200.0m$200.0m$150.0m$150.0m$100.0m$100.0m$50.0m$50.0m$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)2016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029